Skip to main content

Year: 2019

Tauriga Sciences, Inc. Finalizes its Alternative Tauri-Gum Package Designs and Focuses on Large National Retail Chains

New York, NY, Nov. 19, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that is has finalized its alternative Tauri-Gum™ package designs and continues to focus efforts on securing potential orders from large national retail chains (“national retailers”).  The Company has established an alternative package design for its 3 blister pack flavors (Mint, Blood Orange and Pomegranate), which essentially removes the decorative cannabis leaves – while substituting images of each respective fruit/plant.  The Company believes that the availability of these...

Continue reading

IGE+XAO: Statement regarding the total number of shares and voting rights composing the registered capital on 31 October 2019

IGE+XAOSociété Anonyme with capital of 5,021,866.85 eurosHead office : 16 Boulevard Déodat de Séverac31770 COLOMIERS338 514 987 RCS ToulouseSIRET: 338 514 987 000 76 – VAT number: FR 783.385.149.87Regulated informationStatement regarding the total number of shares and voting rights composing the registered capital on 31 October 2019In accordance with the article L.233-8 II of the French Commercial Code and with the article 223-16 of the French Financial Market Authority (AMF) General Rule.Toulouse, 19 November 2019Total number of shares composing the registered capital: 1,304,381Total number of voting rights:Gross (1): 1,334,404Net (2): 1,332,038(1) In conformity with the article 223-11 of the AMF General Rule, the total number of voting rights is calculated on the basis of the whole shares composing the registered capital.(2) The net...

Continue reading

IGE+XAO : Déclaration du nombre total d’actions et de droits de vote composant le capital social au 31 octobre 2019

IGE+XAOSociété Anonyme au capital de 5 021 866,85 eurosSiège social : 16 Boulevard Déodat de Séverac31770 COLOMIERS338 514 987 RCS ToulouseSIRET : 338 514 987 000 76 – N° TVA intracommunautaire : FR 783.385.149.87Information réglementéeDéclaration du nombre total d’actions et de droits de vote composant le capital social au 31 octobre 2019Conformément à l’article L.233-8 II du Code de Commerce et à l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Toulouse, le 19 novembre 2019Nombre total d’actions composant le capital social : 1 304 381Nombre total de droits de vote :Brut (1) : 1 334 404NET (2) : 1 332 038(1) Conformément à l’article 223-11 du Règlement général de l’AMF, le nombre total de droits de vote est calculé sur la base de l’ensemble des actions composant le capital social.(2) Le nombre total net...

Continue reading

12 ReTech Corporation Releases its 3rd Quarter FY2019 Financial Results and Discusses the Significance of its Recent Bluwire Acquisition.

3rd Quarter 2019 Revenues Were Up 345% Over the Same Period in 2018.Adjusted Net Profits Were Generated for the First Time in the Company’s History.Las Vegas, NV & Hong Kong, Nov. 19, 2019 (GLOBE NEWSWIRE) — 12 ReTech Corporation (OTC: RETC), released its 3rd Quarter, 2019 financial results yesterday and showed further progress in improving the operations of their business with increased revenues and decreased operational expenses which resulted in reduced operational losses.The Company has improved its year over year operational results by integrating its three USA acquired consumer micro-brands so that they can work together as a cohesive business unit. This effort has resulted in reduced overhead expenses. With the newly acquired Bluwire Group retail stores, the Company plans to take advantage of additional synergies. Also,...

Continue reading

EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility

WATERTOWN, Mass., Nov. 19, 2019 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced an amendment to its existing debt facility with CRG Servicing LLC (CRG). Under the terms of the amendment, CRG has waived the financial covenant associated with the Company’s product revenue of DEXYCU® and YUTIQ® for the twelve-month period ending on December 31, 2019. There were no other changes made to the term loan agreement.“CRG shares our vision of expanding the reach of DEXYCU® and YUTIQ® across the U.S. on behalf of patients suffering from ocular diseases who have few alternative therapies available,” said George Elston, Chief Financial Officer and Head of Corporate Development of EyePoint Pharmaceuticals....

Continue reading

Laurentian Bank Financial Group launches new offering to help Canadians improve their financial health

MONTREAL, Nov. 19, 2019 (GLOBE NEWSWIRE) — Laurentian Bank Financial Group (TSX: LB) has launched a digital offering for personal customers under the LBC Digital brand. The launch marks a milestone for the organization whose mission is to help its customers improve their financial health.Customers looking for a new banking experience can now open, with straight through on-the-spot processing, chequing accounts, high-interest savings accounts and guaranteed investment certificates from their mobile devices or online. All this, without paperwork or signatures. By opening an account at LBCDigital.ca, they can:Enjoy a great interest rate of 3.30%1 with our high interest savings account (HISA);Perform their daily banking transactions without monthly fees2 through our new digital chequing account;Invest in guaranteed investment certificates...

Continue reading

Banque Laurentienne Groupe Financier lance une nouvelle offre pour aider les Canadiens à améliorer leur santé financière

MONTRÉAL, 19 nov. 2019 (GLOBE NEWSWIRE) — Banque Laurentienne Groupe Financier (TSX: LB) lance son offre numérique destinée aux particuliers sous la marque BLC Numérique. Ce lancement marque l’atteinte d’un jalon important dans la mission que s’est donnée l’organisation d’aider ses clients à améliorer leur santé financière.Les clients à la recherche d’une nouvelle expérience bancaire peuvent dès maintenant ouvrir, de manière automatisée et immédiate, des comptes-chèques, des comptes d’épargne à intérêt élevé et des certificats de placement garanti à partir de leur appareil mobile ou en ligne. Tout cela, sans paperasse et sans signature. En ouvrant un compte sur BLCNumérique.ca, ils pourront :Profiter d’un taux très avantageux de 3,30 %1 avec notre compte d’épargne à intérêt élevé (CEIE);Effectuer leurs opérations bancaires...

Continue reading

Correction: Form 8.3 – AXA INVESTMENT MANAGERS: Consort Medical PLC

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Form 8.3 – AXA INVESTMENT MANAGERS: Consort Medical PLC

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Hammond Power Solutions Declares Quarterly Dividend

GUELPH, Ontario, Nov. 19, 2019 (GLOBE NEWSWIRE) — (TSX: HPS.A) The Board of Directors of Hammond Power Solutions Inc. (“HPS”) declared a quarterly cash dividend of seven cents ($0.07) per Class A Subordinate Voting Share of HPS and a quarterly cash dividend of seven cents ($0.07) per Class B Common Share of HPS payable on December 11, 2019 to shareholders of record at the close of business on December 4, 2019. The ex-dividend date is December 3, 2019.Important Income-Tax Information for Canadian Resident ShareholdersHPS designates the entire amount of this taxable dividend to be an “eligible dividend” for purposes of the Income Tax Act (Canada), as amended from time to time. This notice meets the requirements of the Income Tax Act (Canada). Please contact your tax advisor if you have any questions with regard to the designation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.